Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia
NCT ID: NCT05326607
Last Updated: 2022-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-09-09
2022-01-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of the AcuFocus Corneal Inlay ACI7000PDT in Presbyopes
NCT01352442
Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
NCT07321756
A Comparison of the Visual Performance of Trifocal Versus Extended Depth of Focus Intraocular Lenses
NCT03726606
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
NCT00366496
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT01257217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Arm
Prototype of adaptive eyeglasses
The tested investigational medical device is a prototype of semi-integrated eyeglasses.
Comparator
The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.
Second Arm
Prototype of adaptive eyeglasses
The tested investigational medical device is a prototype of semi-integrated eyeglasses.
Comparator
The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prototype of adaptive eyeglasses
The tested investigational medical device is a prototype of semi-integrated eyeglasses.
Comparator
The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with presbyopia
3. A wearer whose current corrective solution is a pair of progressive lenses that provide clear vision at both distance and near vision (worn at least 5 times per week for 4 hours per day), or, a wearer who has rejected progressive glasses that provide clear vision at both distance and near vision and who uses another corrective solution that provides clear vision at both distance and near vision (bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia)
4. Patient with a distance visual acuity of 10/10 at least with current corrective solution
5. Patient with a visual acuity of P2 at least in near vision with current corrective solution
6. Patient with at least 10/10 distance vision once corrected with contact lenses for the test
7. Inter-pupillary distance in distance vision between 55 and 71mm
8. Distance from temple-to-temple not exceeding 161mm
9. Addition greater than or equal to 1.75D: Add≥1.75D
10. Sphere strictly between -6D and +4D: -6D\<S\<+4D
11. Cylinder below 1.75D:C\<1.75D
12. Patient uses a computer (at least 3 times a week in private and/or work settings).
13. Affiliation to a social security scheme
14. French-speaking (fluent).
15. Patient willing to participate in the study.
Exclusion Criteria
2. Patient unable to understand the study procedures and therefore to provide free and informed consent
3. Patient with reading difficulties
4. Patient with multifocal implants
5. Patient who has undergone multifocal surgery
6. Patient with prism correction
7. Patient with a current or past eye condition that may adversely affect vision
8. Patient being treated or having undergone surgery likely to adversely affect vision
9. Patient with mobility problems that would prevent tests and workshops from being carried out
10. Patient intolerant to wearing contact lenses for a few hours (only for presbyopes with ametropia)
11. Patient who is pregnant or breastfeeding
12. Patient already included once in the study
13. Patient placed in an institution based on a judicial or regulatory ruling, held in psychiatric department, in state-run prison, or employed by the study research sites or by the sponsor.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iris Pharma
INDUSTRY
Laclaree
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno BERGE, PhD
Role: STUDY_CHAIR
SPONSOR: LACLAREE
Jessica JAROSZ, PhD
Role: STUDY_DIRECTOR
SPONSOR: LACLAREE
Philippe GAIN, Prof.
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne Hôpital Nord, Service d'Ophtalmologie 25, boulevard Pasteur
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Jessica Jarosz, Norbert Molliex, Guilhem Chenon, and Bruno Berge, "Adaptive eyeglasses for presbyopia correction: an original variable-focus technology," Opt. Express 27, 10533-10552 (2019)
Jessica Jarosz, Norbert Molliex, Quentin Lavigne, and Bruno Berge "An original low-power opto-fluidic engine for presbyopia-correcting adaptive eyeglasses", Proc. SPIE 10858, Ophthalmic Technologies XXIX, 1085824 (28 February 2019)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00521-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.